 |
|
Sjögren's SyndromeAssociation of Cutaneous Vasculitis With Central Nervous System Disease
Elaine Alexander, MD, PhD;
Thomas T. Provost, MD
Arch Dermatol. 1987;123(6):801-810.
Abstract
• We describe a group of patients with Sjögren's syndrome, who commonly present to dermatologists with cutaneous manifestations of vasculitis. Two specific clinically recognizable forms of cutaneous vasculitis predominate: palpable purpura of the lower extremities (Waldenström's benign hypergammaglobulinemic purpura) and urticarialike vasculitis. Two pathologic types of cutaneous vasculopathy are demonstrated, one leukocytoclastic and the other mononuclear. The leukocytoclastic vasculopathy is associated with high titers of Ro(SS-A) and La(SS-B) autoantibodies (detected by gel doublediffusion techniques) and general serohyperreactivity. In marked contrast, the mononuclear vasculopathy is associated with low titers of Ro(SS-A) and La(SS-B) autoantibodies (detected by enzyme-linked immunosorbent assay but not gel double-diffusion techniques) and general serohyporeactivity. Approximately 70% of patients with Sjögren's syndrome and cutaneous vasculitis have also developed peripheral and/or central nervous system disease. The pathogenesis of the nervous system disease is unknown, but preliminary data suggest a vasculopathy.
(Arch Dermatol 1987;123:801-810)
Author Affiliations
From the Division of Allergy and Clinical Immunology, Department of Medicine (Dr Alexander), and the Department of Dermatology (Dr Provost), The Johns Hopkins Medical Institutions, Baltimore.
Footnotes
Accepted for publication Dec 29, 1986.
Reprint requests to the Department of Dermatology, Blalock 920, The Johns Hopkins Hospital, Baltimore, MD 21202 (Dr Provost).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Review : Grand Rounds from International lupus centres Severe reversible cardiomyopathy associated with systemic vasculitis in primary Sjogren's syndrome
Golan et al.
Lupus 1997;6:505-508.
ABSTRACT
A Clinical Perspective on SPECT
Parker and Austin
Aust N Z J Psychiatry 1995;29:38-47.
ABSTRACT
|
